# FDA Approved Medication to Reduce Binge Eating and/or Purging

> **NCT02553824** · PHASE1 · COMPLETED · sponsor: **Stanford University** · enrollment: 22 (actual)

## Conditions studied

- Binge Eating Disorder
- Bulimia Nervosa

## Interventions

- **DRUG:** Phentermine/Topiramate-First
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02553824
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-30
- **Primary completion:** 2017-02-23
- **Final completion:** 2017-04-15
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2018-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02553824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02553824, "FDA Approved Medication to Reduce Binge Eating and/or Purging". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02553824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*